Safety, Tolerability, and Pharmacokinetics of Raltegravir (MK-0518) in Healthy Japanese Male Participants (MK-0518-851)

Clinical trial NCT03667547 · COMPLETED

Trial details

NCT number: NCT03667547
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Human Immunodeficiency Virus (HIV) Infection

Start date: 2018-09-27
Primary completion: 2018-10-23
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.